questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Mitogen-Activated Protein Kinases
JNK Mitogen-Activated Protein Kinases
JNK Mitogen-Activated Protein Kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "JNK Mitogen-Activated Protein Kinases : Questions médicales les plus fréquentes",
"headline": "JNK Mitogen-Activated Protein Kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les JNK Mitogen-Activated Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "JNK Mitogen-Activated Protein Kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinases",
"url": "https://questionsmedicales.fr/mesh/D020928",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D020928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 8",
"alternateName": "Mitogen-Activated Protein Kinase 8",
"url": "https://questionsmedicales.fr/mesh/D048055",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 8",
"code": {
"@type": "MedicalCode",
"code": "D048055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 9",
"alternateName": "Mitogen-Activated Protein Kinase 9",
"url": "https://questionsmedicales.fr/mesh/D048056",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 9",
"code": {
"@type": "MedicalCode",
"code": "D048056",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 10",
"alternateName": "Mitogen-Activated Protein Kinase 10",
"url": "https://questionsmedicales.fr/mesh/D048057",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 10",
"code": {
"@type": "MedicalCode",
"code": "D048057",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "JNK Mitogen-Activated Protein Kinases",
"alternateName": "JNK Mitogen-Activated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D048031",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohammad Shafiq",
"url": "https://questionsmedicales.fr/author/Mohammad%20Shafiq",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Kumaravelu Jagavelu",
"url": "https://questionsmedicales.fr/author/Kumaravelu%20Jagavelu",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Neeraj Kumar Verma",
"url": "https://questionsmedicales.fr/author/Neeraj%20Kumar%20Verma",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Jimut Kanti Ghosh",
"url": "https://questionsmedicales.fr/author/Jimut%20Kanti%20Ghosh",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Matthias Gaestel",
"url": "https://questionsmedicales.fr/author/Matthias%20Gaestel",
"affiliation": {
"@type": "Organization",
"name": "Institute for Zellbiochemie, Medizinische Hochschule Hannover (MHH), Hanover, Germany (M.G.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Self-Emulsifying Drug Delivery System Enhances Tissue Distribution of Cinnamaldehyde by Altering the Properties of the Mucus Layer.",
"datePublished": "2022-09-21",
"url": "https://questionsmedicales.fr/article/36131215",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1208/s12249-022-02416-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changes in adipose tissue distribution and relation to cardiometabolic risk factors after Roux-en-Y gastric bypass in adolescents.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37296018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.soard.2023.04.326"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution-A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling.",
"datePublished": "2023-11-12",
"url": "https://questionsmedicales.fr/article/38003416",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms242216224"
}
},
{
"@type": "ScholarlyArticle",
"name": "Abnormal Biologic Distribution Related to Normal Saline Among",
"datePublished": "2022-10-04",
"url": "https://questionsmedicales.fr/article/36195444",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnmt.122.264241"
}
},
{
"@type": "ScholarlyArticle",
"name": "Self-assembly and cellular distribution of a series of transformable peptides.",
"datePublished": "2022-05-25",
"url": "https://questionsmedicales.fr/article/35470824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d1tb02814f"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mitogen-Activated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D020928"
},
{
"@type": "ListItem",
"position": 7,
"name": "JNK Mitogen-Activated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D048031"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : JNK Mitogen-Activated Protein Kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur JNK Mitogen-Activated Protein Kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur JNK Mitogen-Activated Protein Kinases",
"description": "Comment diagnostiquer une activation des JNK ?\nQuels biomarqueurs indiquent l'activation des JNK ?\nLes tests génétiques sont-ils utiles pour les JNK ?\nQuels examens d'imagerie sont utilisés pour les JNK ?\nPeut-on mesurer l'activité des JNK dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Tissue+Distribution&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels symptômes sont liés à l'activation des JNK ?\nLes JNK sont-ils impliqués dans des maladies ?\nComment les JNK affectent-ils la douleur ?\nLes JNK influencent-ils le métabolisme ?\nY a-t-il des symptômes neurologiques associés aux JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Tissue+Distribution&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur JNK Mitogen-Activated Protein Kinases",
"description": "Comment prévenir l'activation des JNK ?\nLe stress influence-t-il les JNK ?\nLes antioxydants aident-ils à prévenir l'activation des JNK ?\nL'exercice physique prévient-il l'activation des JNK ?\nLes habitudes alimentaires influencent-elles les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Tissue+Distribution&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels traitements ciblent les JNK ?\nLes anti-inflammatoires affectent-ils les JNK ?\nLa thérapie génique peut-elle cibler les JNK ?\nLes traitements naturels influencent-ils les JNK ?\nLes traitements anticancéreux ciblent-ils les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Tissue+Distribution&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur JNK Mitogen-Activated Protein Kinases",
"description": "Quelles complications sont liées à l'activation des JNK ?\nLes JNK sont-ils liés à des complications cardiovasculaires ?\nLes JNK influencent-ils le vieillissement cellulaire ?\nY a-t-il des complications neurologiques liées aux JNK ?\nLes JNK sont-ils impliqués dans des complications métaboliques ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Tissue+Distribution&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels facteurs de risque influencent les JNK ?\nL'alimentation affecte-t-elle les JNK ?\nLe tabagisme influence-t-il les JNK ?\nL'exposition à des toxines affecte-t-elle les JNK ?\nLe manque d'exercice est-il un facteur de risque pour les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Tissue+Distribution&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation des JNK ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de signalisation cellulaire et des analyses protéomiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs indiquent l'activation des JNK ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de protéines phosphorylées c-Jun peuvent indiquer une activation."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les JNK ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests peuvent identifier des mutations affectant la voie JNK."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont utilisés pour les JNK ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique peut aider à visualiser des effets cellulaires."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer l'activité des JNK dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons sanguins peuvent être analysés pour des marqueurs d'activation."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'activation des JNK ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activation peut entraîner inflammation, apoptose et dysfonction cellulaire."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils impliqués dans des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont associés à des maladies comme le cancer et les maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Comment les JNK affectent-ils la douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils modulent la signalisation de la douleur, contribuant à des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les JNK influencent-ils le métabolisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils jouent un rôle dans la régulation du métabolisme énergétique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés aux JNK ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs et des troubles de l'humeur peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation des JNK ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les JNK ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut activer les JNK, donc la gestion du stress est cruciale."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à prévenir l'activation des JNK ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent réduire le stress oxydatif et l'activation des JNK."
}
},
{
"@type": "Question",
"name": "L'exercice physique prévient-il l'activation des JNK ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler positivement l'activité des JNK."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les JNK ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en nutriments peut réduire l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les JNK ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des JNK sont en développement pour diverses maladies."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires affectent-ils les JNK ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains anti-inflammatoires peuvent moduler l'activité des JNK."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle cibler les JNK ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est explorée pour corriger des dysfonctionnements des JNK."
}
},
{
"@type": "Question",
"name": "Les traitements naturels influencent-ils les JNK ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales peuvent avoir un effet sur l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Les traitements anticancéreux ciblent-ils les JNK ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements anticancéreux visent à inhiber les voies JNK dans les cellules tumorales."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à l'activation des JNK ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activation excessive des JNK peut entraîner des maladies inflammatoires et cancéreuses."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils liés à des complications cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation des JNK est associée à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les JNK influencent-ils le vieillissement cellulaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activation prolongée des JNK peut accélérer le vieillissement cellulaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques liées aux JNK ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation des JNK est impliquée dans des troubles neurodégénératifs."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils impliqués dans des complications métaboliques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont liés à des troubles métaboliques comme le diabète."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les JNK ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, l'inflammation chronique et l'obésité sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'alimentation affecte-t-elle les JNK ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut augmenter l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les JNK ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque qui peut activer les JNK."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle les JNK ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut activer les JNK."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice est-il un facteur de risque pour les JNK ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque d'activation des JNK."
}
}
]
}
]
}
Oral delivery is considered the preferred route of administration due to its convenience and favorable compliance. However, this delivery often faces difficulties, such as poor solubility, limited abs...
Roux-en-Y gastric bypass (RYGB) among adolescents with obesity results in significant weight loss; however, depot-specific changes have been understudied....
We hypothesized that visceral adipose tissue (VAT) reduction in adolescents undergoing RYGB would be greater than other depots and associated with improvement in cardiometabolic risk factors....
Three specialized treatment centers in Sweden....
Fifty-nine adolescents underwent dual x-ray absorptiometry before surgery and at 1, 2, and 5 years after RYGB. Changes in body composition in multiple depots (total fat, lean body, gynoid fat, android...
At 1 year post-RYGB, a significant reduction was observed across all body composition measures (P < .001) with the greatest reduction observed in VAT (-65.1% [-68.7, -61.8]). From year 1 to 5 years po...
Adiposity measures all decreased after RYGB but poorly predicted change in cardiometabolic risk. Despite significant reductions at 1 year, a steady regain was observed out to 5 years, with values stil...
A permeability-limited physiologically based pharmacokinetic (PBPK) model featuring four subcompartments (corresponding to the intracellular and extracellular water of the tissue, the residual plasma,...
The primary aim was to describe the incidence and causes of abnormal distribution of...
Transformable peptides (TPs) are biomedical materials with unique structures and diverse functionalities that have drawn great interest in materials science and nanomedicine. Here, we design a series ...
Controlling the biodistribution of protein- and nanoparticle-based therapeutic formulations remains challenging. In vivo library selection is an effective method for identifying constructs that exhibi...
To investigate the biodistribution and kinetic constants of...
Seven patients who experienced endoscopic resection of gastric neuroendocrine tumor were enrolled. Dynamic total-body PET/CT scans over 60 min were performed. Time-activity curves were obtained by dra...
The highest uptake of...
Uptake and clearance of...
White adipose tissue (WAT) usually shows negligible...
Tumor growth, progression, and metastatic capability in non-Hodgkin lymphomas (NHLs) are influenced by different component of tumor microenvironment, including inflammatory cells. Among these latter, ...
Biological tissues contain various metals and metalloids ions with central role in the regulation of several pathophysiological functions. In parallel, the development and the evaluation of novel nano...